Found: 66
Select item for more details and to access through your institution.
Altered actin cytoskeleton and inhibition of matrix metalloproteinase expression by vanadate and phenylarsine oxide, inhibitors of phosphotyrosine phosphatases: Modulation of migration and invasion of human malignant glioma cells.
- Published in:
- Molecular Carcinogenesis, 1999, v. 26, n. 4, p. 274, doi. 10.1002/(SICI)1098-2744(199912)26:4<274::AID-MC6>3.0.CO;2-1
- By:
- Publication type:
- Article
Corticosteroid Use in Patients with Glioblastoma at First or Second Relapse Treated with Bevacizumab in the BRAIN Study.
- Published in:
- Oncologist, 2010, v. 15, n. 12, p. 1329, doi. 10.1634/theoncologist.2010-0105
- By:
- Publication type:
- Article
Mechanisms underlying PTEN regulation of vascular endothelial growth factor and angiogenesis.
- Published in:
- Annals of Neurology, 2003, v. 53, n. 1, p. 109
- By:
- Publication type:
- Article
Advances in Neuro-Oncology II. Editted by Paul L. Kornblith, MD Michael D. Walker MD Armonk, NY, Futura Publishing Co, 1997, $125.00.
- Published in:
- Annals of Neurology, 1998, v. 43, n. 4, p. 548, doi. 10.1002/ana.410430427
- By:
- Publication type:
- Article
Use of [18F]fluorodeoxyglucose positron emission tomography in patients with primary malignant brain tumors.
- Published in:
- 1993
- By:
- Publication type:
- journal article
?24-hyCD adenovirus suppresses glioma growth in vivo by combining oncolysis and chemosensitization.
- Published in:
- Cancer Gene Therapy, 2005, v. 12, n. 3, p. 284, doi. 10.1038/sj.cgt.7700750
- By:
- Publication type:
- Article
A novel E1A-E1B mutant adenovirus induces glioma regression in vivo.
- Published in:
- Oncogene, 2004, v. 23, n. 10, p. 1821, doi. 10.1038/sj.onc.1207321
- By:
- Publication type:
- Article
Activation of WEE1 confers resistance to PI3K inhibition in glioblastoma.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 1, p. 78, doi. 10.1093/neuonc/nox128
- By:
- Publication type:
- Article
Brain Malignancy Steering Committee clinical trials planning workshop: Report from the Targeted Therapies Working Group.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 2, p. 180, doi. 10.1093/neuonc/nou154
- By:
- Publication type:
- Article
PHASE II TRIAL OF THE PHOSPHATIDYINOSITOL-3 KINASE (PI3K) INHIBITOR BUPARLISIB (BKM120) IN RECURRENT GLIOBLASTOMA CONDUCTED BY THE IVY FOUNDATION EARLY PHASE CLINICAL TRIALS CONSORTIUM.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. suppl_3, p. iii47, doi. 10.1093/neuonc/nou209.20
- By:
- Publication type:
- Article
IDH1/2 mutations target a key hallmark of cancer by deregulating cellular metabolism in glioma.
- Published in:
- Neuro-Oncology, 2013, v. 15, n. 9, p. 1114, doi. 10.1093/neuonc/not087
- By:
- Publication type:
- Article
From GWAS risk foci to glioma molecular subclass.
- Published in:
- Neuro-Oncology, 2013, v. 15, n. 5, p. 513, doi. 10.1093/neuonc/not061
- By:
- Publication type:
- Article
Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02.
- Published in:
- Neuro-Oncology, 2012, v. 14, n. 12, p. 1511, doi. 10.1093/neuonc/nos264
- By:
- Publication type:
- Article
New impact factor reflects increased quality.
- Published in:
- Neuro-Oncology, 2012, v. 14, n. 9, p. 1115, doi. 10.1093/neuonc/nos201
- By:
- Publication type:
- Article
A Year of Continued Growth and Success.
- Published in:
- Neuro-Oncology, 2012, v. 14, n. 1, p. 1, doi. 10.1093/neuonc/nor225
- By:
- Publication type:
- Article
Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 10, p. 1118
- By:
- Publication type:
- Article
New impact factor number reflects sustained and enhanced growth.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 9, p. 925, doi. 10.1093/neuonc/nor128
- By:
- Publication type:
- Article
Identification of novel synergistic targets for rational drug combinations with PI3 kinase inhibitors using siRNA synthetic lethality screening against GBM.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 4, p. 367, doi. 10.1093/neuonc/nor012
- By:
- Publication type:
- Article
AMPK/TSC2/mTOR-signaling intermediates are not necessary for LKB1-mediated nuclear retention of PTEN tumor suppressor.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 2, p. 184, doi. 10.1093/neuonc/noq163
- By:
- Publication type:
- Article
The Problem with Cell Phones … or Maybe Not.
- Published in:
- Neuro-Oncology, 2010, v. 12, n. 11, p. 1087, doi. 10.1093/neuonc/noq159
- By:
- Publication type:
- Article
Impact factor number reflects sustained high quality.
- Published in:
- Neuro-Oncology, 2010, v. 12, n. 9, p. 893, doi. 10.1093/neuonc/noq105
- By:
- Publication type:
- Article
Review of the complexities of the PI3K/mTOR pathway presages similar handling of other critical topics.
- Published in:
- Neuro-Oncology, 2010, v. 12, n. 8, p. 763, doi. 10.1093/neuonc/noq083
- By:
- Publication type:
- Article
Journal to shift practice on obtaining conflict of interest declarations.
- Published in:
- Neuro-Oncology, 2010, v. 12, n. 7, p. 619, doi. 10.1093/neuonc/noq064
- By:
- Publication type:
- Article
Cellular and in vivo activity of a novel PI3K inhibitor, PX-866, against human glioblastoma.
- Published in:
- Neuro-Oncology, 2010, v. 12, n. 6, p. 559, doi. 10.1093/neuonc/nop058
- By:
- Publication type:
- Article
Tumor stem cells, notch, and the news.
- Published in:
- Neuro-Oncology, 2010, v. 12, n. 2, p. 115, doi. 10.1093/neuonc/nop055
- By:
- Publication type:
- Article
Neuro-Oncology turns a page.
- Published in:
- Neuro-Oncology, 2010, v. 12, n. 1, p. 1, doi. 10.1093/neuonc/nop037
- By:
- Publication type:
- Article
Modeling prognosis for patients with malignant astrocytic gliomas: Quantifying the expression of multiple genetic markers and clinical variables.
- Published in:
- Neuro-Oncology, 2005, v. 7, n. 4, p. 485, doi. 10.1215/S1152851704000730
- By:
- Publication type:
- Article
13-cis -Retinoic acid in the treatment of recurrent glioblastoma multiforme.
- Published in:
- Neuro-Oncology, 2004, v. 6, n. 3, p. 253, doi. 10.1215/S1152851703000607
- By:
- Publication type:
- Article
Phase 2 study of BCNU and temozolomide for recurrent glioblastoma multiforme: North American Brain Tumor Consortium study.
- Published in:
- Neuro-Oncology, 2004, v. 6, n. 1, p. 33, doi. 10.1215/S1152851703000309
- By:
- Publication type:
- Article
Phase 1/1b study of lonafarnib and temozolomide in patients with recurrent or temozolomide refractory glioblastoma.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 15, p. 2747, doi. 10.1002/cncr.28031
- By:
- Publication type:
- Article
Phase 2 trial of irinotecan and thalidomide in adults with recurrent anaplastic glioma.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 14, p. 3599, doi. 10.1002/cncr.26663
- By:
- Publication type:
- Article
A novel CRM1-dependent nuclear export signal in adenoviral E1A protein regulated by phosphorylation.
- Published in:
- FASEB Journal, 2006, v. 20, n. 14, p. 2603, doi. 10.1096/fj.06-6433fje
- By:
- Publication type:
- Article
Two phase II trials of temozolomide with interferon-alpha2b (pegylated and non-pegylated) in patients with recurrent glioblastoma multiforme.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Expression of Transcription Factor E2F1 and Telomerase in Gliobtastomas: Mechanistic Linkage and Prognostic Significance.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 21, p. 1589, doi. 10.1093/jnci/dji340
- By:
- Publication type:
- Article
Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium Trial.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma.
- Published in:
- Cancer (0008543X), 2004, v. 100, n. 8, p. 1712
- By:
- Publication type:
- Article
Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy.
- Published in:
- Cancer (0008543X), 2003, v. 98, n. 5, p. 1021
- By:
- Publication type:
- Article
Molecular Classification of Human Diffuse Gliomas by Multidimensional Scaling Analysis of Gene Expression Profiles Parallels Morphology-Based Classification, Correlates with Survival, and Reveals Clinically-Relevant Novel Glioma Subsets.
- Published in:
- Brain Pathology, 2002, v. 12, n. 1, p. 108, doi. 10.1111/j.1750-3639.2002.tb00427.x
- By:
- Publication type:
- Article
Modulation of Serine Proteinases and Metalloproteinases During Morphogenic Glial-Endothelial Interactions.
- Published in:
- Journal of Neurochemistry, 1996, v. 66, n. 4, p. 1657, doi. 10.1046/j.1471-4159.1996.66041657.x
- By:
- Publication type:
- Article
EGFR suppresses p53 function by promoting p53 binding to DNA-PKcs: a noncanonical regulatory axis between EGFR and wild-type p53 in glioblastoma.
- Published in:
- Neuro-Oncology, 2022, v. 24, p. 1712, doi. 10.1093/neuonc/noac105
- By:
- Publication type:
- Article
Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experience.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 8, p. 1252, doi. 10.1093/neuonc/noab082
- By:
- Publication type:
- Article
PARP-mediated PARylation of MGMT is critical to promote repair of temozolomide-induced O<sup>6</sup>-methylguanine DNA damage in glioblastoma.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 6, p. 920, doi. 10.1093/neuonc/noab003
- By:
- Publication type:
- Article
Radiographic read paradigms and the roles of the central imaging laboratory in neuro-oncology clinical trials.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 2, p. 189, doi. 10.1093/neuonc/noaa253
- By:
- Publication type:
- Article
ATIM-37. SAFETY RUN-IN RESULTS OF A PHASE I/II STUDY TO EVALUATE THE SAFETY AND CLINICAL EFFICACY OF ATEZOLIZUMAB (ATEZO; aPDL1) IN COMBINATION WITH TEMOZOLOMIDE (TMZ) AND RADIATION IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM).
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi9, doi. 10.1093/neuonc/noy148.032
- By:
- Publication type:
- Article
EXTH-11. GLIOBLASTOMA STEM CELL GROWTH DEPENDENCE ON NUTRIENTS: MORE THAN BASAL METABOLIC ACTIVITIES.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi87, doi. 10.1093/neuonc/noy148.360
- By:
- Publication type:
- Article
Integrated analysis of telomerase enzymatic activity unravels an association with cancer stemness and proliferation.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-020-20474-9
- By:
- Publication type:
- Article
Differential expression of epidermal growth factor receptor in human head and neck cancers.
- Published in:
- Head & Neck, 1998, v. 20, n. 4, p. 320, doi. 10.1002/(SICI)1097-0347(199807)20:4<320::AID-HED7>3.0.CO;2-0
- By:
- Publication type:
- Article
Gamma-radiation sensitivity and risk of glioma.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Treatment of Recurrent Gliomas With Eflornithine.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1992, v. 84, n. 18, p. 1432, doi. 10.1093/jnci/84.18.1432
- By:
- Publication type:
- Article
Identification of Common Prognostic Gene Expression Signatures with Biological Meanings from Microarray Gene Expression Datasets.
- Published in:
- PLoS ONE, 2012, v. 7, n. 9, p. 1, doi. 10.1371/journal.pone.0045894
- By:
- Publication type:
- Article